GlassScriptPhysician profile
Edgar B Galloway
NPI 1841299567
$4,775.06
in general payments reported to CMS, 2019-2025
22 companies · $719 in 2025
The $719 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $870 · 2020: $545 · 2021: $604 · 2022: $502 · 2023: $624 · 2024: $911 · 2025: $719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,660 · Travel and Lodging: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,659.84 |
| Travel and Lodging | $594.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,536.22 | 2019-2024 | Scopis Ent, Audion Et Dilation System |
| Astrazeneca Pharmaceuticals LP | $808.66 | 2019-2025 | Tezspire |
| Glaxosmithkline, LLC. | $510.31 | 2019-2023 | Nucala |
| Medtronic, INC. | $484.77 | 2021-2025 | Propel |
| Aerin Medical INC. | $290.98 | 2019-2025 | |
| Genzyme Corporation | $290.88 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $153.20 | 2022-2025 | Dupixent |
| Inspire Medical Systems, INC. | $116.15 | 2021 | |
| Optinose US, INC. | $93.14 | 2019-2024 | |
| Neurent Medical Limited | $83.06 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Agiliti Surgical, INC. | $73.41 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.47 | 2021-2024 | Takhzyro |
| Intersect Ent, INC. | $49.12 | 2019-2020 | |
| Shire North American Group INC | $39.83 | 2019 | |
| Arrinex, INC. | $39.77 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $30.92 | 2024 | Coolseal Generator |
| Amgen INC. | $28.07 | 2025 | Tezspire |
| Acclarent, INC | $20.25 | 2019 | |
| Innovation Technologies INC | $19.95 | 2024 | Irrisept |
| Teva Pharmaceuticals USA, INC. | $19.14 | 2022 | |
| Coherus Oncology, INC. | $14.01 | 2024 | |
| Sanofi Pasteur INC. | $11.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Galloway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.